UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease Journal article
Vu, Mylinh, Li, Rong, Baskfield, Amanda, Lu, Billy, Farkhondeh, Atena, Gorshkov, Kirill, Motabar, Omid, Beers, Jeanette, Chen, Guokai, Zou, Jizhong, Espejo-Mojica, Angela J., Rodriguez-Lopez, Alexander, Almeciga-Diaz, Carlos J., Barrera, Luis A., Jiang, Xuntian, Ory, Daniel S., Marugan, Juan J., Zheng, Wei. Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease[J]. ORPHANET JOURNAL OF RARE DISEASES, 2018, 13.
Authors:  Vu, Mylinh;  Li, Rong;  Baskfield, Amanda;  Lu, Billy;  Farkhondeh, Atena; et al.
Favorite | TC[WOS]:25 TC[Scopus]:31  IF:3.4/3.9 | Submit date:2018/10/30
Tay-sachs Disease  Induced Pluripotent Stem Cells  Neural Stem Cells  Cyclodextrin  Hp Beta Cd  Delta-tocopherol  Enzyme Replacement Therapy  Hexosaminidase a  Gm2 Gangliosidosis  High Throughput Screening  Drug Discovery  
The antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells Journal article
Sarah A. Head, Wei Shi, Liang Zhao, Kirill Gorshkov, Kalyan Pasunooti, Yue Chen, Zhiyou Deng, Ruo-jing Li, Joong Sup Shim, Wenzhi Tan, Thomas Hartung, Jin Zhang, Yingming Zhao, Marco Colombini, Jun O. Liu. The antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112(52), E7276-E7285.
Authors:  Sarah A. Head;  Wei Shi;  Liang Zhao;  Kirill Gorshkov;  Kalyan Pasunooti; et al.
Favorite | TC[WOS]:83 TC[Scopus]:88  IF:9.4/10.8 | Submit date:2019/01/24
Angiogenesis  Mitochondria  Metabolism  Itraconazole  Vdac1